Stockscreener 앱 받기
3.59
5.77%
-0.22
시간 외 거래:
3.58
-0.010
-0.28%
Whitehawk Therapeutics Inc 주식(WHWK)의 최신 뉴스
Pullback Watch: Does Whitehawk Therapeutics Inc have a sustainable dividendWeekly Stock Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Market Wrap: What are Whitehawk Therapeutics Incs earnings expectationsLong Setup & Long-Term Safe Investment Plans - baoquankhu1.vn
Inside Whitehawk's 3 next-gen cancer drug conjugates debuting at AACR 2026 - Stock Titan
Whitehawk Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aug Patterns: How does Whitehawk Therapeutics Inc score in quality rankingsMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
Whitehawk Therapeutics Inc PE Ratio (TTM) & PE Ratio (TTM) ChartsWHWK - GuruFocus
Suvretta Capital Management LLC Buys Shares of 3,700,000 Whitehawk Therapeutics, Inc. $WHWK - MarketBeat
2,849,402 Shares in Whitehawk Therapeutics, Inc. $WHWK Purchased by Avoro Capital Advisors LLC - MarketBeat
Whitehawk Therapeutics (WHWK) Swings To US$0.37 EPS Profit Challenging Bearish Turnaround Skepticism - simplywall.st
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rapid Micro Biosystems (RPID), Lexicon Pharmaceuticals (LXRX) and Whitehawk Therapeutics (WHWK) - The Globe and Mail
Whitehawk Therapeutics Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Whitehawk Therapeutics 2025 10-K Overview: Next-Generation ADC Cancer Therapies, Pipeline, and Strategic Partnerships - Minichart
WHITEHAWK THERAPEUTICS ($WHWK) Releases Q4 2025 Earnings - Quiver Quantitative
Whitehawk Therapeutics Q4 EPS $(0.34) Misses $(0.13) EstimateWhitehawk Therapeutics (NASDAQ:WHWK) - Benzinga
Whitehawk Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs - TradingView
Whitehawk Therapeutics (WHWK) boosts 2025 cash to $145.7M and advances ADC pipeline - Stock Titan
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PR Newswire
Whitehawk Therapeutics (WHWK) price target increased by 11.11% to 5.10 - MSN
David James Lennon Sells 5,100 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock - MarketBeat
Whitehawk Therapeutics (WHWK) CEO sells shares to cover RSU tax - Stock Titan
Whitehawk Therapeutics (WHWK) CFO sells shares to cover tax bill - Stock Titan
Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027 - MarketBeat
Whitehawk Therapeutics (WHWK) officer vests 5,000 RSUs, small tax sale - Stock Titan
Jones Trading initiates coverage of Whitehawk Therapeutics (WHWK) with buy recommendation - MSN
Why Whitehawk Therapeutics Inc. stock is a value investor pickEarnings Beat & Verified Chart Pattern Trade Signals - Naître et grandir
Insider Trends: What are the risks of holding Whitehawk Therapeutics IncWeekly Risk Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Can Whitehawk Therapeutics Inc reach resistance levels soon2025 Market Trends & Low Risk Entry Point Guides - baoquankhu1.vn
Aadi Bioscience Conference: Whitehawk CEO Details 3-Program ADC Pipeline, First Data Seen in 2027 - Defense World
Aug Closing: Can Whitehawk Therapeutics Inc reach resistance levels soonJuly 2025 Short Interest & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Whitehawk Therapeutics : Corporate Presentation March 2026 - marketscreener.com
WHWK: Three differentiated ADCs in parallel, targeting broad cancers with best-in-class stability and safety - TradingView
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PR Newswire
Cancer drug developer Whitehawk lines up three March investor talks - Stock Titan
Whitehawk Therapeutics (WHWK) Price Target Increased by 11.11% to 5.10 - Nasdaq
Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028 - Yahoo Finance
WHWK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WHWKWhitehawk Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Cancer drug developer Whitehawk joins Oppenheimer health conference - Stock Titan
Can Whitehawk Therapeutics Inc. (3350) stock sustain double digit ROEJuly 2025 Chart Watch & Low Risk Entry Point Guides - mfd.ru
Can Whitehawk Therapeutics Inc. (3350) stock reach $200 price targetMarket Sentiment Report & Daily Entry Point Trade Alerts - mfd.ru
How Whitehawk Therapeutics Inc. stock reacts to global recession fearsTrade Entry Summary & Fast Momentum Entry Tips - mfd.ru
Will Whitehawk Therapeutics Inc. outperform tech stocksJuly 2025 Volume & High Win Rate Trade Tips - mfd.ru
Is Whitehawk Therapeutics Inc.’s growth already priced in2025 Fundamental Recap & High Accuracy Investment Entry Signals - mfd.ru
Published on: 2026-02-13 19:37:08 - baoquankhu1.vn
Will Whitehawk Therapeutics Inc. stock deliver strong dividend growthChart Signals & Long-Term Capital Growth Strategies - mfd.ru
Is Whitehawk Therapeutics Inc. stock technically oversold2025 Major Catalysts & Reliable Price Breakout Alerts - mfd.ru
Oppenheimer Begins Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - Defense World
Oppenheimer initiates Whitehawk Therapeutics (WHWK) with Outperform Feb 2026 - Meyka
Oppenheimer Initiates Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Trading 0.7% HigherStill a Buy? - MarketBeat
Retail Trends: Can FreightCar America Inc be recession proofJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Investment Recap: Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Whitehawk Therapeutics (WHWK) price target increased by 125.00% to 4.59 - MSN
Support Test: Should I set a stop loss on Onfolio Holdings IncTake Profit & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Whitehawk Therapeutics Inc sustain its profitability2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth - simplywall.st
1.20%
0.06%
자본화:
|
볼륨(24시간):